Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 7, 2014; 20(33): 11574-11585
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11574
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11574
miRNA | Body fluid | Level of expression | Clinical application | Ref. |
miR-200c | Blood | Up-regulated | Progression and survival | [140] |
miR-421 | Gastric Juice | Up-regulated | Screening | [141] |
miR-21 | Gastric Juice | Up-regulated | Screening | [142] |
miR-106a | Gastric Juice | Up-regulated | Screening | [142] |
miR-129-1-3p | Gastric Juice | Down-regulated | Screening | [137] |
miR-129-2-3p | Gastric Juice | Down-regulated | Screening | [137] |
miR-335 | Blood | Up-regulated | Recurrence and prognostic | [143] |
miR-221 | Serum | Up-regulated | Screening | [144] |
miR-744 | Serum | Up-regulated | Screening | [144] |
miR-376c | Serum | Up-regulated | Screening | [144] |
miR-199a-3p | Plasma | Up-regulated | Progression, screening | [145] |
- Citation: Pinheiro DDR, Ferreira WAS, Barros MBL, Araújo MD, Rodrigues-Antunes S, Borges BDN. Perspectives on new biomarkers in gastric cancer: Diagnostic and prognostic applications. World J Gastroenterol 2014; 20(33): 11574-11585
- URL: https://www.wjgnet.com/1007-9327/full/v20/i33/11574.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i33.11574